Neurological Emergencies Treatment Trials - Antihypertensive Treatment of Acute Cerebral Hemorrhage-II (NETT # ATACH II): A Phase III Randomized Multicenter Clinical Trial of Blood Pressure Reduction for Hypertension in Acute Intracerebral Hemorrhage

Grants and Contracts Details


Intensive SBP reduction using IV nicardipine with treatment initiated within 3 hours of ICH onset and continued for the next 24 hours reduces the likelihood of death or disability at Day 90 (defined by mRS of 4-6) by absolute 10% (or relative 17%) or greater compared with standard SBP reduction using IV nicardipine.
Effective start/end date10/1/137/31/16


  • University of Michigan: $15,888.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.